Mass General Brigham · 2 months ago
Post-Doctoral Research Fellow
Mass General Brigham is a not-for-profit organization that supports patient care, research, teaching, and community service. They are seeking a Post-Doctoral Research Fellow to conduct research on non-coding RNAs in relation to vascular diseases, with a focus on understanding their mechanisms and functions.
Health CareHome Health CareMedical
Responsibilities
Understanding the role of non-coding RNAs (miRNAs/lncRNAs) and their signaling pathways/targets in a range of vascular disease states including atherosclerosis and ischemic injury in the heart and limb with a major focus in diabetes
Understanding the mechanisms and functions of identified non-coding RNAs in cell types important to cardiovascular disease and diabetes such as endothelial cells, vascular smooth muscle cells, and leukocyte subsets
Understanding specific aspects of non-coding RNAs and target gene function in vitro and in vivo using mouse knockout, knockdown, or overexpression studies, and translational assessment in human specimens
Qualification
Required
Strong background in molecular and cellular biology, or vascular biology
Outstanding written and verbal communication skills
Self-motivated
Demonstrated productivity
Ability to be independent while also working in a team environment
Candidates must be able to make a 2-year commitment
Degree Required: Ph.D. or M.D
Preferred
Experience in molecular biology and mice
Company
Mass General Brigham
Mass General Brigham specializes in providing medical treatments and health diagnostics services.
H1B Sponsorship
Mass General Brigham has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (77)
2024 (61)
2023 (93)
2022 (70)
2021 (80)
2020 (29)
Funding
Current Stage
Late StageLeadership Team
Recent News
2026-01-17
2026-01-17
2026-01-17
Company data provided by crunchbase